|
Generic Name
Nom générique
|
Designation
|
Brand Name
Nom commercial
|
|
|
|
|
|
Abagovomab
|
|
|
|
Abexinostat
(hydrochloride)
|
PCI-24781
CRA-024781
|
|
|
Abiraterone acetate
|
CB7630
|
Zytiga
|
|
Adecatumumab
|
|
|
|
Aderbasib
|
INCB 007839
|
|
|
Afatinib
|
BIBW2992
|
Tovok
|
|
Aflibercept
|
AVE0005
VEGF Trap
VEGF-Trap
NSC 724770
|
Zaltrap
|
|
Afutuzumab
|
|
|
|
Agatolimod
|
PF-3512676
|
|
|
Alacizumab
|
|
|
|
Alemtuzumab
|
|
Campath
|
|
Alisertib
|
MLN8237-004
|
|
|
Altumomab
|
|
|
|
Alvespimycin
|
KOS-1022
|
|
|
Alvespimycin
hydrochloride
|
BMS-826476
|
|
|
Alvocidib
|
Flavopiridol
HL-275
HMR-1275
L86-8275
MDL-107826A
NSC-649890
|
|
|
Amatuximab
|
MORAb-009
|
|
|
Amonafide ???
|
|
|
|
Amrubicin hydrochloride
|
SM-5887
|
|
|
Amuvatinib
|
MP-470
MP470
HPK-56
MP470.HCl
|
|
|
Anamorelin hydrochloride
|
RC-1291 HCl
|
|
|
Anatumomab
|
|
|
|
Angiopoietin-2
|
REGN910 SAR307746
|
|
|
Apatinib
|
YN968D1
|
|
|
Apaziquone
|
EO9
|
EOquin, Neoquin
|
|
Apolizumab
|
|
|
|
Apricoxib
|
TG01
R-109339
CS-706
|
|
|
Arcitumomab
|
|
|
|
Astuprotimut-R
|
GSK-249553
SB-249553
MAGE-A3 ASCI
|
|
|
Axitinib
|
AG-13736
AG-013736
|
|
|
Azacitidine
|
|
Vidaza
|
|
Azacitidine 5’
elaidic ester
|
CP-4200
|
|
|
Bafetinib
|
INNO-406
NS-187
|
|
|
Balamapimod
|
MKI-833
|
|
|
Bardoxolone
|
RTA 401
CDDO
|
|
|
Bardoxolone methyl
|
RTA 402
CDDO-Me
NSC 713200
|
|
|
Bavituximab
|
3G4
|
Tarvacin
|
|
Bectumomab
|
|
|
|
Belagenpumatucel-L
|
|
Lucanix
|
|
Belimumab
|
|
|
|
Belinostat
|
PXD101
NSC 726630
|
|
|
Belotecan hydrochloride
|
CKD-602
|
|
|
Berubicin hydrochloride
|
RTA 744
WP744
|
|
|
Besilesomab
|
|
|
|
Bevacizumab
|
|
Avastin
|
|
Bivatuzumab mertansine
|
|
|
|
Blinatumomab
|
MEDI-538
MT-103
MT103
|
|
|
Bortezomib
|
|
Velcade
|
|
Bosutinib
|
SKI-606
PF-5208763
SKI-758
|
|
|
Brentuximab vedotin
|
SGN-35
SGN35
cAC10-vcMMAE
|
Adcetris
|
|
Brivanib
|
BMS-540215
|
|
|
Brivanib alaninate
|
BMS-582664
|
|
|
Cabazitaxel
|
XRP-6258
|
|
|
Cabozantinib (s-malate)
|
XL184
XL 184
EXEL-7184
BMS 907351
|
|
|
Calaspargase (pegol)
|
EZN-2285
|
|
|
Camptothecin
|
IT-101
CRLX101
|
Cyclosert-CPT
|
|
Canertinib
|
CI-1033
|
|
|
Cantuzumab mertansine
|
|
|
|
Cantuzumab ravtansine
|
huC242-DM4 IMGN242
|
|
|
Capromab pendetide
|
|
|
|
Carfilzomib
|
PR-171
|
|
|
Carlecortemcel-l
|
|
StemEX
|
|
Carlumab
|
CNTO 888
|
|
|
Catumaxomab
|
|
|
|
Cediranib (maleate)
|
AZD2171 (maleate)
|
Recentin
|
|
Cenersen sodium
|
OL(1)p53, EL625
|
|
|
Cetuximab
|
|
Erbitux
|
|
Cevipabulin (fumarate or succinate)
|
TTI-237
|
|
|
Chidamide
|
HBI-8000
CS055
|
|
|
Cilengitide
|
EMD 121974
EMD121974
|
|
|
Citatuzumab bogatox
|
|
|
|
Cixutumumab
|
IMC-A12
|
|
|
(Yttrium Y90) Clivatuzumab tetraxetan
|
hPAM4-DOTA
IMMU-107
90hY-PAM4
|
|
|
Conatumumab
|
AMG 655
TRAIL-R2 mAb
|
|
|
Contusugene ladenovec
|
Ad5CMV-p53
INGN 201
|
|
|
Cordecepin or Cordycepin
|
BU-01
OVI-123
|
|
|
Cositecan
Karenitecin
|
BNP1350
|
|
|
Crenolanib (besylate), formerly plarotinib
|
ARO-002(-26)
CP-868,596(-26)
CP-868596, ARO-002
|
|
|
Crisantaspase, Erwinia chrysanthemi L-asparaginase
|
|
Erwinase, Erwinaze (USA)
|
|
Crizotinib
|
PF-2341066
PF-2,341,066
PF-02341066
PF1066
PF-1066
|
Xalkori
|
|
Crolibulin
|
EPC2407
|
|
|
Custirsen sodium
|
OGX-011
ISIS 112989
|
|
|
Cytarabine:daunorubicin
|
CPX-351
|
|
|
Dabrafenib (mesylate)
|
GSK-2118436(B)
|
|
|
Dacetuzumab
|
SGN-40
huS2C6
|
|
|
Dacomitinib
|
PF-299
PF299804
PF-00299804
PF-299,804, PF00299804
|
|
|
Dalantercept
|
ACE-041
|
|
|
Dalotuzumab
|
MK-0646
|
|
|
Danusertib
|
PHA-739358
|
|
|
Darinaparsin
|
ZIO-101
|
|
|
Dasatinib
|
BMS-354825
|
Sprycel
|
|
Daunorubicin citrate liposome
|
NSC 82151
|
DaunoXome
|
|
DCVax-Brain
|
|
DCVax-L Brain
|
|
Decitabine
|
|
Dacogen
|
|
Defibrotide
|
|
|
|
Deforolimus
|
???
|
|
|
Degarelix acetate
|
FE200486
|
Firmagon
|
|
Delanzomib
|
CEP18770
CT47098
NPH007098
|
|
|
Demcizumab
|
OMP-21M18
|
|
|
Denenicokin
|
L-methionyl(human interleukin-21)
IL-21
rIL-21
recombinant human interleukin 21
|
|
|
Denibulin hydrochloride
|
MN- 029
|
|
|
Denosumab
|
|
|
|
Desmethyl Erlotinib
|
OSI-420, CP-473420
|
|
|
Detumomab
|
|
|
|
Dinaciclib
|
SCH 727965
|
|
|
Disomotide
|
MPS-22
|
|
|
Dovitinib
|
TKI258
CHIR-258
|
|
|
Doxorubicin (zoptarelin)
|
AN-152
AN 152
ZEN-008
AEZS-108
DOX-LTSL
|
ThermoDox
|
|
Drozitumab
|
PRO95780
anti-DR5
rhuMAb DR5
|
|
|
Dulanermin
|
Apo2L/TRAIL
PRO1762
TRAIL/Apo2L
AMG 951
rhApo2L
RG3639
|
|
|
Dusigitumab
|
|
|
|
Ecromexumab
|
|
|
|
Edotecarin
|
PF-804950
|
|
|
Edrecolomomab
|
|
|
|
Efatutazone
|
CS7017
CS-7017
|
|
|
Elacytarabine
|
CP-4055
|
Elacyt
|
|
Elagolix
|
NBI-56418
|
|
|
Elagolix sodium
|
NBI-56418 Na
|
|
|
Elesclomol
|
STA-4783
|
|
|
Elisidepsin
|
PM02734
|
Irvalec
|
|
Elotuzumab
|
HuLuc63
PDL063
PDL-063
BMS-901608
|
|
|
Emepepimut-S
|
L-BLP25, BLP-25
(formerly BP1-7-KLH), EMD531444
|
Stimuvax
|
|
Enavatuzumab
|
PDL 192
|
|
|
Eniluracil
|
GW776C85
ADH300004
|
Cytefuran
|
|
Ensituximab
|
NPC-1C
|
|
|
Entinostat
|
MS275
SNDX-275
MS-275
|
|
|
Enzalutamide
|
MDVN 300 series
MDV3100
|
|
|
Enzastaurin
|
LY317615
|
|
|
Epetirimod mesylate
|
851B
S-30563-35-65
|
|
|
Epitinib
|
HMPL-813
|
|
|
Epratuzumab
|
Y90 MAb LL2, 90Y-hLL2, IMMU-103, hLL2, hCD22, AMG 412
|
LymphoCide Y-90
|
|
Eribulin mesylate
|
E7389
|
|
|
Erismodegib
|
LDE225
|
|
|
Erlotinib
|
|
Tarceva
|
|
Ertumaxomab
|
|
|
|
Etaracizumab
|
Etaratuzumab
MEDI-522
|
Abegrin
Vitaxin
|
|
Everolimus
|
|
Afinitor
|
|
Falimarev
|
PANVAC-F
CVAC-301, formerly
Panvac-VF
|
|
|
Famitinib
|
|
|
|
Farletuzumab
|
MORAb-003
|
|
|
Ficlatuzumab
|
SCH900105
AV299
AV-299
SCH 900105
|
|
|
Figitumumab
|
CP-751,871
|
|
|
Flanvotumab
|
IMC-20DS7
|
|
|
Flumatinib
|
HHGV678, HH-GV678, HH-GV-678
|
|
|
Folitixorin calcium
|
ANX-510
CoFactor
|
|
|
Foretinib
|
GSK1363089G
XL880
|
|
|
Forodesine
|
BCX-1777
immucillin-H
|
Fodosine
|
|
Fosbretabulin (tromethamine)
|
combretastatin-A4 phosphate
CA4P
|
Zybrestat
|
|
Fostamatinib
|
R7935788
|
|
|
Fostamatinib disodium
|
R788
R-788
R935788 sodium
|
|
|
Fresolimumab
|
GC1008
|
|
|
Fruquintinib
|
HMPL-013
|
|
|
Galactomycin
|
GM-CT-01 (formerly Davanat-1)
|
Pro-5FU
|
|
Galeterone
|
TOK-001
VN/124-1
VN/124
SARM/LI
|
|
|
Galgenprostucel-L
|
CG1940
|
GVAX™ Prostate
|
|
Galiximab
|
|
|
|
Ganetespib
|
STA-9090
|
|
|
Ganitumab
|
AMG 479
|
|
|
Gataparsen (sodium)
|
LY2181308
heptadecasodium salt
|
|
|
Gefitinib
|
|
Iressa
|
|
Gemcitabine 5'-elaidic acid ester
|
CP-4126
O-1.01
CO-101
|
|
|
Gemtuzumab ozogamicin
|
|
|
|
Girentuximab
|
WX-G250
cG250
anti-G250, cG250
|
|
|
(Iodine I124)
girentuximab
|
124IcG250
|
Redectane
|
|
Givinostat
|
ITF2357
|
|
|
Glembatumumab vedotin
|
CR011-vcMMAE,
CDX-011
|
|
|
Glufosfamide
|
D-19575
|
|
|
Golnerminogene
pradenovec
|
ADgv EGR.TNF.11D
|
|
|
Histrelin
|
Formerly RL0903
|
Vantas
|
|
Ibritumomab tiuxetan
|
|
|
|
Icotinib
|
BPI-2009-H
|
|
|
Icrucumab
|
IMC-18F1
IMC18F1
LY3012212
|
|
|
Igovomab
|
|
|
|
Imatinib
|
|
|
|
Imatinib Mesylate
|
STI-571, STI571,
formerly CGP-57148B
|
Gleevec (USA, Canada, Israel), Glivec (Europe)
|
|
Imetelstat
|
GRN163L
formerly GRN719
|
|
|
Imgatuzumab
|
|
|
|
Inalimarev
|
PANVAC-V
CVAC-301, formerly
Panvac-VF
|
|
|
Indatixumab ravtansine
|
|
|
|
Indibulin
|
ZIO-301
D-24851
|
|
|
Indisulam
|
E7070
|
|
|
Ingenol mebutate
|
PEP-005
|
|
|
Intedanib
|
BIBF1120
|
|
|
Intetumumab
|
CNTO-95
CNTO 095
CNTO 95
|
|
|
Iniparib
|
BSI-201
|
|
|
Inotuzumab ozogamicin
|
|
|
|
Interferon-alpha 2b
|
|
Biphasix
|
|
Iobenguane I 131
|
MIP-120T, Ultratrace MIBG
|
Azedra, Ultratrace iobenguane I-131
|
|
Ioflubenzamide I131
|
BA-100
MIP-1145
|
|
|
Ipilimumab
|
MDX-010
MDX-CTLA-4
|
Yervoy
|
|
Iratumumab
|
MDX-060
|
|
|
Irosustat
|
BN83495
STX64
667 Coumate
|
|
|
Ispinesib
|
SB-715992
|
|
|
Labetuzumab
|
|
|
|
Lansoprazole
|
|
PrevOnco
|
|
Lapatinib (ditosylate)
|
572016, GW572016, GW 572016, GSK 572016
|
Tykerb (USA, EU), Tyverb
|
|
Lapuleucel-T
|
APC8024, BA7072,
DN24-02
|
Neuvenge
|
|
Laromustine
|
VNP40101M, 101M
|
|
|
Lenalidomide
|
CDC501, CDC-501,
CDC-5013, CC5013, CC-5013
|
Revlimid (formerly Revimid), Lenalidomide-Celgene Europe
|
|
Lenvatinib
|
ER-203492-00
|
|
|
Lenvatinib mesylate
|
E7080
|
|
|
Lestaurtinib
|
CEP-701
KT-5555
|
|
|
Leukocyte interleukin injection
|
|
Multikine
|
|
Leuprolide acetate
|
|
Enanton
|
|
Lexatumumab
|
|
|
|
Lexibulin
|
CYT997
|
|
|
Linifanib
|
ABT-869
RG3635
|
|
|
Linsitinib
|
OSI-906
OSI-906AA
|
|
|
Lintuzumab
|
|
|
|
Litronesib
|
LY2523355
KF89617
|
|
|
Lonafarnib
|
SCH66336
|
|
|
Lonaprisan
|
ZK 230211
|
|
|
Lorvotuzumab mertansine
|
huN901-DM1, BB-10901TAP, BB-10901, IMGN901
|
|
|
Lucatumumab
|
CHIR-12.12
HCD-122
|
|
|
Lumiliximab
|
|
|
|
Mapatumumab
|
|
|
|
Marizomib
|
NPI-0052
|
|
|
Masitinib (mesylate)
|
Masivet
AB1010
|
|
|
Matuzumab
|
|
|
|
Melphalan
|
|
Percutaneous Hepatic Perfusion (PHP)
|
|
Milatuzumab
|
IMMU-115
|
|
|
Mitumomab
|
|
|
|
Mituprotimut-T
|
Id/KLH
|
|
|
Mocetinostat
|
MGCD0103
|
|
|
Mocetinostat dihydrobromide
|
|
|
|
Mogamulizumab
|
KW-0761
KM8761
|
|
|
Motesanib (diphosphate)
|
AMG-706
AMG706
|
|
|
Moxetumomab pasudotox
|
CAT-8015
HA22
|
|
|
Mubritinib
|
TAK165
|
|
|
Nacolomab tafenatox
|
|
|
|
Naptumomab estafenatox
|
|
|
|
Narnatumab
|
IMC-RON8
IMC RON-8
RON8
|
|
|
Navitoclax dihydrochloride
|
ABT-263
RG7423
A-855071.0
|
|
|
Necitumumab
|
IMC-11F8
|
|
|
Neratinib
|
HKI-272
PF-05208767
|
|
|
Nesvacumab
|
|
|
|
Nilotinib
|
AMN-107
|
Tasigna
|
|
Nimotuzumab
|
|
|
|
Niraparib
|
MK-4827
|
|
|
Nivolumab
|
|
|
|
Nofetumomab merpentan
|
|
|
|
Obatoclax
|
GX15-070
|
|
|
Obinutuzumab
|
Ro-5072759
huMAB
GA-101
Afutuzumab
|
|
|
Ocaratuzumab
|
|
|
|
Ofatumumab
|
GSK1841157
HuMax-CD20
2F2
|
|
|
Olaparib
|
AZD2281
KU-0059436
|
|
|
Olaratumab
|
IMC-3G3
IMC3G3
|
|
|
Omacetaxine mepesuccinate
|
CGX-635
Homoharringtonine
|
|
|
Onartuzumab
|
PRO143966
MetMAb
RG3638
|
|
|
Oportuzumab monatox
|
|
|
|
Oregovomab
|
|
OvaRex
|
|
Orteronel
|
TAK-700
|
|
|
Oxaliplatin (L-OHP)
|
1670RB, RP 54780
|
Eloxatin, Eloxatine, Elplat
|
|
Paclitaxel
|
ANG1005
GRN1005
MBT-0206
EndoT-1
|
OncoJan
EndoTAG-1
|
|
Palifosfamide
|
IPM
ZIO-201
|
|
|
Panitumumab
|
|
Vectibix
|
|
Panobinostat
|
LBH-589
LBH 589
LBH589
NVP-LBH589
LBH489B
LBH489A
|
|
|
Parsatuzumab
|
|
|
|
Patritumab
|
|
|
|
Pazopanib
|
|
Votrient
|
|
Pegdinetanib
|
BMS-844203
CT-322
CT322
|
Adnectin, Angiocept, formerly TriNectin
|
|
Pelitinib
|
EKB-569
|
|
|
Pemtumomab
|
|
|
|
Perifosine
|
KRX-0401
D-21266
|
|
|
Pertuzumab
|
RG1273
R1273
2C4
rhuMAb-2C4
|
Perjeta (formerly Omnitarg)
|
|
Pictilisib
|
GDC-0941
|
|
|
Pidilizumab
|
|
|
|
Pintumomab
|
|
|
|
Pixantrone dimaleate
|
BBR 2778
|
Pixuvir
Pixantrone
|
|
Plinabulin
|
NPI-2358
|
|
|
Plitidepsin
Dehydrodidemnin B
|
|
Aplidin R Aplidine
|
|
Ponatinib
|
AP24534
|
|
|
Pritumumab
|
|
|
|
Quarfloxin
|
CX-3543
|
|
|
Quizartinib
|
AC220
AC010220
|
|
|
Racotumomab
|
1E10
|
|
|
Radium223 Chloride
|
|
Alpharadin
|
|
Radretumab
|
|
|
|
Ramucirumab
|
IMC-1121b
IMC 1121B
LY3009806
|
|
|
Ranagengliotucel-T
|
|
Glionix
|
|
Ranpirnase
|
Formerly P-30 protein
|
Onconase
|
|
Regorafenib
|
BAY 73-4506
|
|
|
Resminostat
|
4SC-201
BYK408740
|
|
|
Retaspimycin
hydrochloride
|
IPI-504
MEDI-561
|
|
|
Ridaforolimus
|
AP23573
MK-8669
|
|
|
Rigosertib sodium
|
ON 01910.Na
|
Estybon
|
|
Rindopeptimut
|
PF-04948568
PF4948568
CDX-110
ALT-110
|
|
|
Rilotumumab
|
AMG 102
|
|
|
Rituximab
|
|
Rituxan
|
|
Robatumumab
|
SCH 717454
|
|
|
Romidepsin
|
|
Istodax
|
|
Ropidoxuridine
|
IPdR
|
|
|
Rucaparib
|
AG-14447
|
|
|
Rucaparib phosphate
|
AG014699
PF01367338
|
|
|
Ruxolitinib (phosphate)
|
INC424
INCB018424 (salt)
|
|
|
Sagopilone
|
DE-03757
ZK 219477
SHY03757,
SH-Y03757A
ZK-219477
ZK-epothilone
BAY86-5302
|
ZK-EPO
|
|
Salirasib
|
farnesyl thiosalicylic
acid
|
|
|
Samalizumab
|
ALXN6000
|
|
|
Sapacitabine
|
CYC682
CS-682
|
|
|
Saracatinib
|
AZD0530
|
|
|
Saracatanib fumarate
|
AZD0530 fumarate
|
|
|
Saridegib
|
IPI-926
|
|
|
Satumomab pendetide
|
|
|
|
Seliciclib
|
R-roscovitine CYC-202
|
|
|
Selumetinib
|
AZD6244
ARRY-142886
ARRY-886
|
|
|
Selumetinib sulfate
|
AZD6244 Hydrogen Sulfate
|
|
|
Semaxinib
|
SU5416
|
|
|
Sepantronium (bromide)
|
YM155
|
|
|
Sibrotuzumab
|
|
|
|
Siltuximab
|
CNTO-328
|
|
|
Sivifene
|
A-007
|
|
|
Solitomab
|
MT110
|
|
|
Sorafenib (tosylate)
|
BAY 43-9006 (BAY 54-9085)
|
Nexavar
|
|
Sotatercept
|
ACE-011
|
|
|
Squalamine
|
MSI-1256F
|
Evizon (ophthalmic)
|
|
|
ALT-801, 264scTCR/IL-2, c264scTCR-IL2
|
STAR/IL-2
|
|
Sulfatinib
|
HMPL-012
|
|
|
Sunitinib
|
|
Sutent
|
|
Tabalumab
|
|
|
|
Tacatuzumab tetraxetan
|
|
|
|
Talactoferrin alfa,
talactoferrin
|
|
|
|
Talimogene Laherparepvec
|
OncoVEX GM-CSF,
OncoVEXGMCSF, OncoVEXGM-CSF,
JS1 34.5-hGMCSF 47-
pA-
|
|
|
Tamoxifen citrate
|
|
Soltamox
|
|
Tandutinib
|
MLN0518
MLN518
MLN-518
(formerly CT53518,
CT-53518)
|
|
|
Tanespimycin
|
KOS-953
|
|
|
Tasisulam sodium
|
LY573636
|
|
|
Tasquinimod
|
ABR-215050
|
Tumor Angiogenesis
Suppression by Quinolines (TASQ)
|
|
Teglanirad chloride
|
GMX1777
EB1627
|
|
|
Telatinib
|
BAY 57-9352
|
|
|
Telotristat
|
LP-778902
|
|
|
Temsirolimus
|
|
Torisel
|
|
Tenatimomab
|
|
|
|
Tenifatecan
|
SN2310
|
|
|
Teprotumumab
|
RO4858696-000
|
|
|
Theliatinib
|
HMPL-309
|
|
|
Tigatuzumab
|
R-161460
TRA-8
CS-1008
|
|
|
Tipapkinogene sovacivec
|
TG-4001
TG4001
MVA-HPV-IL2
R3484
RO5217790
|
|
|
Tipifarnib
|
R115777
|
Zarnestra
|
|
Tivantinib
|
ARQ-650RP
ARQ 650RP
ARQ 197
ARQ197
|
|
|
Tivozanib
|
AV-951
AV951
Formerly KRN-951
|
|
|
Tosedostat
|
CHR-2797
|
|
|
Tositumomab
|
|
|
|
Tozasertib lactate
|
MK-0457
VX-680
|
|
|
Trametinib
|
GSK1120212
|
|
|
Trastuzumab
|
|
Herceptin
|
|
Trastuzumab emtansine
|
PRO132365
trastuzumab-MCC-DM1
T-DM1
Trastuzumab-DM1
R3502
RG3502
|
|
|
Trebananib
|
AMG-386
|
|
|
Tremelimumab (formerly ticilimumab)
|
CP-675,206, CP-675, CP-675206
|
|
|
Ublituximab
|
|
|
|
Urelumab
|
BMS-663513
|
|
|
Valrubicin
|
AD32
|
Valstar, Valtaxin
|
|
Vandetanib
|
ZD6474
AZD6474
AZD-6474
|
Caprelsa (formerly
Zictifa and Zactima)
|
|
Varlitinib
|
ARRY-334543
|
|
|
Varlitinib tosylate
|
AR00334543
ARRY-334543
ARRY-543
|
|
|
Vatalanib
|
PTK787
|
|
|
Veltuzumab
|
IMMU-106
|
|
|
Veliparib
|
ABT-888, NSC 737664
|
|
|
Veltuzumab
|
IMMU-106, hA20, hCD20
|
|
|
Vemurafenib
|
PLX-4032
RG7204
R7204
RO5185426
|
Zelboraf
|
|
Verubulin
|
MPC-6827
MX-128495
|
Azixa
|
|
Veltuzumab
|
|
|
|
Vincristine sulfate liposomes for injection (VSLI)
|
|
Marqibo (formerly Onco
TCS), Vincristine Optisome
|
|
Vinflunine ditartrate
|
BMS-710485
F-12158
|
Javlor
|
|
Vinorelbine tartrate
|
ANX-530
Formerly SDP-012
|
Exelbine
|
|
Vintafolide
|
EC145
|
|
|
Vismodegib
|
GDC-0449
Cur-691
RG3616
|
HhAntag
|
|
Volasertib
|
BI6727
|
|
|
Volociximab
|
|
|
|
Volitinib
|
HMPL-504
|
|
|
Vorinostat
|
|
Zolinza
|
|
Vosaroxin
|
SNS-595
SPC-595, Fformerly
AG-7352,
Formerly voreloxin
|
|
|
Votumumab
|
|
|
|
Zalutumumab
|
HuMax-EGFr
2F8
|
|
|
Zanolimumab
|
|
|
|
Zatuximab
|
|
|
|
Zibotentan
|
ZD4054
|
|
|
|
|
|
